Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1179
4.850
 Why?
Early Detection of Cancer
6
2020
167
2.440
 Why?
Ultrasonography, Mammary
8
2020
60
2.090
 Why?
Colorectal Neoplasms
4
2018
236
1.580
 Why?
Mass Screening
3
2020
346
1.550
 Why?
Healthcare Disparities
3
2017
268
1.130
 Why?
Mastectomy
13
2019
141
1.110
 Why?
Mastectomy, Segmental
7
2018
91
1.090
 Why?
Sentinel Lymph Node Biopsy
10
2015
117
1.030
 Why?
Community Health Planning
3
2018
28
1.010
 Why?
Ultrasonography, Interventional
5
2020
136
0.860
 Why?
Biopsy, Needle
10
2015
181
0.850
 Why?
Focus Groups
1
2024
191
0.850
 Why?
Neoplasm Staging
14
2024
738
0.840
 Why?
Biopsy, Large-Core Needle
3
2020
31
0.830
 Why?
Female
55
2024
26635
0.800
 Why?
Genetic Counseling
1
2022
38
0.780
 Why?
Health Status Disparities
3
2015
194
0.770
 Why?
Lymph Nodes
7
2015
263
0.770
 Why?
Neoplasms
5
2015
1249
0.760
 Why?
Patient Education as Topic
1
2024
313
0.740
 Why?
Image Interpretation, Computer-Assisted
1
2020
106
0.700
 Why?
Middle Aged
40
2024
12206
0.680
 Why?
Image-Guided Biopsy
2
2020
33
0.670
 Why?
Hematoma
4
2018
66
0.660
 Why?
Surgery, Computer-Assisted
2
2018
56
0.650
 Why?
Polymorphism, Single Nucleotide
2
2018
485
0.640
 Why?
Humans
60
2024
50209
0.630
 Why?
Mandatory Programs
1
2018
23
0.610
 Why?
Adiposity
1
2019
133
0.600
 Why?
Faculty, Medical
3
2021
92
0.590
 Why?
Health Care Costs
1
2018
170
0.580
 Why?
Aged
31
2024
9405
0.580
 Why?
Adult
32
2024
13325
0.570
 Why?
Insurance Coverage
1
2018
102
0.560
 Why?
Disease Management
1
2018
176
0.540
 Why?
Diagnostic Imaging
1
2018
177
0.540
 Why?
Minority Groups
3
2015
132
0.530
 Why?
Arkansas
9
2018
1985
0.510
 Why?
Retrospective Studies
19
2022
6134
0.490
 Why?
Physicians
1
2018
230
0.480
 Why?
Health Planning Councils
1
2014
6
0.470
 Why?
Community-Based Participatory Research
2
2015
200
0.440
 Why?
Health Policy
1
2014
154
0.420
 Why?
Rural Population
1
2017
537
0.420
 Why?
Follow-Up Studies
11
2018
2190
0.420
 Why?
Aged, 80 and over
14
2018
3154
0.410
 Why?
Qualitative Research
3
2024
336
0.400
 Why?
Community Networks
2
2015
50
0.390
 Why?
Community-Institutional Relations
1
2011
46
0.390
 Why?
Primary Health Care
2
2024
360
0.390
 Why?
Carcinoma, Lobular
2
2015
33
0.380
 Why?
Carcinoma, Ductal, Breast
4
2015
90
0.380
 Why?
Population Surveillance
1
2012
164
0.370
 Why?
Physicians, Women
2
2021
22
0.360
 Why?
Neoplasm Recurrence, Local
6
2014
613
0.350
 Why?
Women's Health
1
2010
89
0.340
 Why?
Health Education
2
2008
155
0.330
 Why?
Needs Assessment
2
2024
133
0.330
 Why?
Medical Oncology
1
2010
95
0.330
 Why?
Breast Diseases
4
2018
26
0.320
 Why?
Nipples
5
2013
33
0.300
 Why?
Schools, Medical
2
2020
70
0.300
 Why?
Axilla
6
2015
90
0.300
 Why?
Health Knowledge, Attitudes, Practice
1
2012
486
0.290
 Why?
Socioeconomic Factors
3
2018
579
0.290
 Why?
Morbidity
2
2018
134
0.290
 Why?
Health Services Accessibility
1
2011
399
0.280
 Why?
Physician-Patient Relations
2
2012
141
0.270
 Why?
Catheter Ablation
4
2014
123
0.260
 Why?
Mammaplasty
3
2013
43
0.260
 Why?
Prognosis
9
2024
1954
0.260
 Why?
Mentors
1
2006
55
0.260
 Why?
Lymphatic Metastasis
7
2015
227
0.250
 Why?
Survivors
2
2024
125
0.250
 Why?
Occult Blood
2
2017
22
0.250
 Why?
United States
7
2022
4874
0.240
 Why?
Young Adult
5
2024
3981
0.240
 Why?
Magnetic Resonance Imaging
5
2014
1541
0.230
 Why?
Referral and Consultation
2
2024
285
0.220
 Why?
Education, Medical, Graduate
2
2022
205
0.220
 Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.210
 Why?
Male
13
2022
25399
0.200
 Why?
Empathy
1
2002
46
0.200
 Why?
Problem-Based Learning
1
2002
47
0.200
 Why?
Atrial Fibrillation
1
2024
183
0.190
 Why?
Emotions
1
2023
164
0.190
 Why?
Breast
2
2020
84
0.190
 Why?
Democratic Republic of the Congo
1
2020
4
0.190
 Why?
Genetic Testing
1
2022
119
0.190
 Why?
Dermatologic Surgical Procedures
3
2013
34
0.190
 Why?
Counseling
1
2022
132
0.190
 Why?
Feasibility Studies
2
2020
380
0.180
 Why?
Combined Modality Therapy
4
2018
636
0.180
 Why?
Biopsy, Fine-Needle
1
2020
103
0.180
 Why?
Research Support as Topic
1
2020
46
0.170
 Why?
Students, Medical
1
2002
155
0.170
 Why?
General Surgery
1
2021
106
0.170
 Why?
Obesity
1
2008
1108
0.170
 Why?
Surgical Flaps
2
2019
120
0.170
 Why?
Prospective Studies
10
2024
2379
0.160
 Why?
Incidence
2
2024
1006
0.160
 Why?
Patient Satisfaction
2
2019
275
0.160
 Why?
Radiopharmaceuticals
4
2008
208
0.150
 Why?
Adipose Tissue
1
2019
187
0.150
 Why?
Logistic Models
2
2018
889
0.140
 Why?
Diagnosis, Differential
1
2020
1043
0.140
 Why?
Lymphatic Vessels
2
2008
48
0.140
 Why?
Rural Health
1
2017
88
0.140
 Why?
Odds Ratio
1
2018
546
0.140
 Why?
Internship and Residency
1
2022
441
0.140
 Why?
Zambia
3
2024
3
0.140
 Why?
Mammography
1
2016
94
0.130
 Why?
Rural Health Services
1
2018
164
0.130
 Why?
Cytodiagnosis
2
2013
42
0.130
 Why?
Genetic Predisposition to Disease
1
2018
509
0.130
 Why?
Case-Control Studies
1
2018
1126
0.130
 Why?
Cross-Sectional Studies
3
2021
1554
0.130
 Why?
Risk Assessment
2
2018
1262
0.130
 Why?
National Cancer Institute (U.S.)
1
2015
32
0.120
 Why?
Survival Rate
1
2017
901
0.120
 Why?
Uterine Cervical Neoplasms
1
2017
276
0.120
 Why?
Algorithms
1
2018
618
0.120
 Why?
Career Mobility
2
2021
28
0.110
 Why?
Patient Care Planning
1
2013
67
0.110
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
40
0.110
 Why?
Monitoring, Intraoperative
3
2014
54
0.110
 Why?
Education, Medical
2
2006
112
0.110
 Why?
Sigmoidoscopy
1
2012
10
0.100
 Why?
Reagent Kits, Diagnostic
1
2012
18
0.100
 Why?
Health Services
1
2012
67
0.100
 Why?
Colonoscopy
1
2012
92
0.100
 Why?
Lymph Node Excision
4
2008
137
0.090
 Why?
Reproducibility of Results
1
2015
1185
0.090
 Why?
Feces
1
2012
131
0.090
 Why?
Treatment Outcome
9
2017
5155
0.090
 Why?
Receptors, Estrogen
2
2015
131
0.090
 Why?
Lymphedema
2
2008
43
0.090
 Why?
Pancreatic Neoplasms
1
2013
208
0.090
 Why?
Fructose
1
2010
22
0.090
 Why?
Clinical Competence
1
2013
392
0.090
 Why?
Registries
1
2013
522
0.090
 Why?
Patient Compliance
1
2012
230
0.090
 Why?
Carbon
1
2010
54
0.090
 Why?
Risk Factors
3
2024
3629
0.090
 Why?
History, 21st Century
1
2010
55
0.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
990
0.080
 Why?
Carcinoma in Situ
2
2006
72
0.080
 Why?
Patient Acceptance of Health Care
1
2012
328
0.080
 Why?
Delivery of Health Care
1
2011
310
0.080
 Why?
Models, Theoretical
2
2006
174
0.070
 Why?
Prochlorperazine
1
2006
6
0.070
 Why?
Postoperative Nausea and Vomiting
1
2006
20
0.070
 Why?
Sensitivity and Specificity
3
2004
863
0.070
 Why?
Education, Medical, Continuing
1
2006
68
0.070
 Why?
Antiemetics
1
2006
32
0.070
 Why?
Receptor, erbB-2
1
2006
74
0.070
 Why?
Body Weights and Measures
1
2005
17
0.070
 Why?
Predictive Value of Tests
2
2013
905
0.060
 Why?
Biopsy
2
2004
590
0.060
 Why?
Intraoperative Care
2
2003
54
0.060
 Why?
Gadolinium
1
2005
43
0.060
 Why?
Interprofessional Relations
1
2006
85
0.060
 Why?
Tissue Expansion Devices
1
2004
3
0.060
 Why?
Neuromuscular Agents
1
2004
7
0.060
 Why?
Neoadjuvant Therapy
2
2017
117
0.060
 Why?
Botulinum Toxins, Type A
1
2004
13
0.060
 Why?
Imaging, Three-Dimensional
1
2005
153
0.060
 Why?
Life Expectancy
1
2024
34
0.060
 Why?
Contrast Media
1
2005
185
0.060
 Why?
Cytological Techniques
1
2003
14
0.060
 Why?
Anthracyclines
1
2024
29
0.060
 Why?
Pain, Postoperative
1
2004
158
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
44
0.060
 Why?
Neoplasm Grading
2
2014
123
0.060
 Why?
Preoperative Care
3
2014
166
0.050
 Why?
Surgical Instruments
1
2002
28
0.050
 Why?
Humanism
1
2002
8
0.050
 Why?
Life Change Events
1
2002
35
0.050
 Why?
Foreign-Body Migration
1
2002
32
0.050
 Why?
Confidence Intervals
1
2002
156
0.050
 Why?
Career Choice
1
2002
111
0.050
 Why?
Sexism
1
2021
10
0.050
 Why?
Program Development
1
2002
167
0.050
 Why?
Image Processing, Computer-Assisted
1
2002
246
0.050
 Why?
Leadership
1
2021
101
0.040
 Why?
Neoplasm Invasiveness
2
2010
266
0.040
 Why?
Vacuum
2
2011
13
0.040
 Why?
Curriculum
1
2002
400
0.040
 Why?
Stereotaxic Techniques
2
2010
37
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
44
0.040
 Why?
Gene Frequency
1
2017
94
0.030
 Why?
Injections, Intralesional
2
2008
31
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
89
0.030
 Why?
Adolescent
3
2013
6390
0.030
 Why?
Guidelines as Topic
1
2016
111
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
202
0.030
 Why?
Regression Analysis
1
2017
395
0.030
 Why?
Coloring Agents
2
2007
70
0.030
 Why?
Neovascularization, Pathologic
1
2017
162
0.030
 Why?
Radionuclide Imaging
2
2007
118
0.030
 Why?
Educational Status
1
2016
223
0.030
 Why?
Genotype
1
2017
534
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
Receptors, Progesterone
1
2015
64
0.030
 Why?
Cohort Studies
2
2011
1422
0.030
 Why?
Cyclophosphamide
1
2015
166
0.030
 Why?
Touch
1
2013
25
0.030
 Why?
Ultrasonography, Doppler
1
2014
42
0.030
 Why?
Carcinoma
1
2015
139
0.030
 Why?
Angiogenesis Inhibitors
1
2015
188
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
225
0.030
 Why?
Disease-Free Survival
1
2014
454
0.030
 Why?
Kaplan-Meier Estimate
1
2014
465
0.030
 Why?
Cicatrix
1
2011
40
0.020
 Why?
Microscopy, Phase-Contrast
1
2010
12
0.020
 Why?
Plant Lectins
1
2010
8
0.020
 Why?
Glycosylation
1
2010
101
0.020
 Why?
Substrate Specificity
1
2010
193
0.020
 Why?
Actins
1
2010
119
0.020
 Why?
Tumor Cells, Cultured
1
2010
468
0.020
 Why?
Cell Movement
1
2010
249
0.020
 Why?
Breast Neoplasms, Male
1
2009
6
0.020
 Why?
Pilot Projects
1
2011
697
0.020
 Why?
Arm
1
2008
47
0.020
 Why?
Phenotype
1
2010
733
0.020
 Why?
Cost-Benefit Analysis
1
2008
273
0.020
 Why?
Positron-Emission Tomography
1
2008
294
0.020
 Why?
Administration, Rectal
1
2006
11
0.020
 Why?
Cell Line, Tumor
1
2010
1416
0.020
 Why?
Probability
1
2006
164
0.020
 Why?
Primary Prevention
1
2006
44
0.020
 Why?
Drug Administration Schedule
1
2006
377
0.020
 Why?
Administration, Oral
1
2006
434
0.020
 Why?
Carcinoma, Ductal
1
2004
9
0.020
 Why?
Tissue Expansion
1
2004
4
0.020
 Why?
Pectoralis Muscles
1
2004
6
0.020
 Why?
Rectus Abdominis
1
2004
7
0.020
 Why?
Spasm
1
2004
9
0.020
 Why?
Laser Coagulation
1
2004
26
0.020
 Why?
Multivariate Analysis
1
2006
581
0.020
 Why?
Cryosurgery
1
2004
36
0.010
 Why?
Sampling Studies
1
2004
37
0.010
 Why?
Statistics, Nonparametric
1
2004
193
0.010
 Why?
Chi-Square Distribution
1
2004
278
0.010
 Why?
Injections
1
2003
56
0.010
 Why?
Pain Measurement
1
2004
240
0.010
 Why?
Ultrasonography
1
2004
437
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1378
0.010
 Why?
Length of Stay
1
2004
621
0.010
 Why?
Reoperation
1
2002
454
0.010
 Why?
Analgesics, Opioid
1
2004
557
0.010
 Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (256) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department